Abstract
First Interim Analysis of the Italian Dante Study: De-Escalation before Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with First-Line Nilotinib
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have